Lipolysisplaysacentralroleintheregulationofenergybalance.Lipolysisistheprocessinwhichtriglycerides(TG)arehydrolyzedintoglycerolandfreefattyacids.Thisprocessreleasesfreefattyacids(FFA)intothebloodstreamwheretheymaybeeitherre-esterifiedbytheADIpocyteortraveltoothertissuesandexertothereffectsthroughoutthebody.Elevatedadipocytelipolysishasbeenobservedinobeseanddiabeticindividuals(Arner1996).Excessivefreefattyacidproductionisbelievedtocontributetoinsulinresistanceinskeletalmusclethatisobservedinobesity.Hormonesensitivelipaseistherate-limitingenzymecatalyzingtriglyceridebreakdown.Perilipins,oneofthePAT(perilipins,adipophilin,TIP47proteins)familyoflipid-associatedproteins,areimplicatedinadipocytelipolysisbymediatingtheinteractionofHSLwiththetriacylglycerolmolecule(Brasaemleetal.2004;reviewedin,Tanseyetal.2004.)Thepresenceoftheseproteinscorrespondstolipolyticstimulationinculturedadipocytes(Braemleetal.2004).
Thesympatheticnervoussystemalsoplaysakeyroleintheregulationoflipidmobilization.Themainlipolyticpathwayinvolvesbeta-agoNISTs(β-agonists),whichactivateβ-adrenergicreceptorsviatheintracellularGsproteinsinadipocytes.Thisleadstotheactivationofadenylatecyclase(AC),whichthenincreasescyclicAMP(cAMP)levels.ElevatedcAMPactsasasecondmessengertoactivatehormonesensitivelipase(HSL).HSL,therate-limitingenzymeregulatingadipocytelipolysis,thencatalyzesthehydrolysisoftriglyceridesandresultsinthereleaseofglycerolandFFA(increasedlipolysis).Phosphodiesterases(PDE)areenzymesthathydrolyzecAMPto5"-AMP(5primeadenosinemonophosphate).Thisactionresultsinadecreaseinlipolysis.PDEinhibitorsincreaseintracellularcAMPlevels.3-isobutyl-1-methylxanthine(IBMX),anon-specificinhibitorofcAMPphosphodiesterases(PDE),isusedasthepositivecontrolifyourtestcompoundsaresUSPectedPDEinhibitors.Isoproterenol,anon-specificβ-adrenergicagonistisusedasthepositivecontrolifyourtestcompoundsaffectlipolysisviaβ-adrenergicreceptors(Robidouxetal.2004).
Ourlipolysisassaykitsprovidethetooltostudychemicalcompoundsthatmayinfluencelipolysisinculturedhumanor3T3-L1adipocytes.Kitsareavailablewithandwithoutaplateofcells.Kitscanmeasuretheglyceroland/orfreefattyacidsreleasedinlipolysis.
Zenbio成立于1995年,自其成立起就在持续供货和扩大研发方面一直处于领先地位,Zenbio以其国际水平的技术支持和专注的客户服务,得到了广泛的认可。Zenbio的成立致力于满足研究人员对肥胖者、糖尿病和心血管疾病研究的迫切需要。尽管啮齿类动物模型对研究新陈代谢各种通路极为有用,但人体的病理学研究关键分析仍需要适合的体外模型,用以研究人的脂肪细胞。而Zenbio能够为研究者提供多种细胞作为病理学研究模型。产品主要包括人类原代细胞、细胞系、培养基、及代谢疾病和药用化妆品等方面的检测试剂盒。